Skip to main content
Premium Trial:

Request an Annual Quote

DNAVision, RNTech to Co-Market Biobanking, Genotyping Services

NEW YORK, Sept. 19 (GenomeWeb News) - DNAVision and RNTech have agreed to co-market an oncology biomarker-discovery platform based on RNTech's oncology tissue bank and DNAVision's gene expression and genotyping services, the companies said today.

 

DNAVision, a spin-off of the University of Brussels, offers expression profiling, SNP genotyping, and sequencing services.

 

RNTech was founded in 2002 and is based in Paris.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.